Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
106 studies found for:    ACR16
Show Display Options
Rank Status Study
1 Completed A Study of Treatment With ACR16 in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
2 Completed A Study of ACR16 for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
3 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
4 Completed
Has Results
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Tocilizumab;   Drug: Placebo
5 Active, not recruiting
Has Results
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast;   Drug: Placebo
6 Completed
Has Results
Dosing Flexibility Study in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Certolizumab pegol;   Other: Placebo
7 Active, not recruiting
Has Results
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast;   Drug: Placebo
8 Active, not recruiting
Has Results
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast;   Drug: Placebo
9 Active, not recruiting
Has Results
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast;   Drug: Placebo
10 Terminated
Has Results
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Apremilast 30 mg;   Drug: Apremilast 20 mg;   Drug: Placebo
11 Completed
Has Results
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Conditions: Arthritis;   Arthritis, Rheumatoid;   Autoimmune Diseases
Interventions: Drug: Golimumab 50 mg SC;   Drug: Golimumab 2 mg/kg IV;   Drug: Methotrexate (MTX);   Drug: Placebo SC;   Drug: Placebo IV
12 Completed
Has Results
Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept , Methotrexate;   Drug: Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide
13 Completed
Has Results
Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Other: Placebo;   Biological: Certolizumab Pegol (CZP) 200 mg;   Biological: Certolizumab Pegol (CZP) 400 mg
14 Terminated
Has Results
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy
Condition: Arthritis, Rheumatoid
Interventions: Drug: ofatumumab;   Drug: Placebo
15 Terminated
Has Results
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CNTO 148 (Golimumab);   Drug: Placebo;   Drug: Methotrexate
16 Completed
Has Results
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Golimumab;   Drug: MTX;   Drug: Placebo;   Drug: Infliximab
17 Completed
Has Results
A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: Adalimumab;   Drug: CP-690-550;   Drug: CP-690,550;   Drug: Placebo
18 Completed Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
Condition: Rheumatoid Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
19 Completed
Has Results
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550;   Other: placebo
20 Terminated
Has Results
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy
Condition: Arthritis, Rheumatoid
Interventions: Drug: Ofatumumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years